Primary biliary cholangitis is an autoimmune liver disease that predominantly affects women.
It is characterised by a chronic and destructive, small bile duct, granulomatous lymphocytic …

Up to 40% of patients with primary biliary cholangitis have an incomplete response to first-
line treatment with ursodeoxycholic acid. Obeticholic acid was approved by the US Food …

Primary biliary cholangitis (PBC) is a chronic cholestatic autoimmune liver disease
characterized by a destructive, small duct, and lymphocytic cholangitis, and marked by the …

Primary biliary cholangitis (formerly known as primary biliary cirrhosis, PBC) is an
autoimmune liver disease in which a cycle of immune mediated biliary epithelial cell injury …

Primary biliary cirrhosis is a chronic cholestatic liver disease characterised by destruction of
small intrahepatic bile ducts, leading to fibrosis and potential cirrhosis through resulting …

Primary biliary cholangitis (PBC) is a chronic inflammatory autoimmune cholestatic liver
disease, which when untreated will culminate in end-stage biliary cirrhosis. Diagnosis is …

Primary biliary cholangitis is a chronic, seropositive and female-predominant inflammatory
and cholestatic liver disease, which has a variable rate of progression towards biliary …

Primary biliary cirrhosis is a chronic cholestatic liver disease of adults. This disorder is
characterised histologically by chronic non-suppurative destruction of interlobular bile ducts …

Primary biliary cholangitis (PBC) is an autoimmune chronic cholestatic liver disease
characterized by biliary destruction and progressive intrahepatic cholestasis. PBC primarily …

Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by biliary
destruction, progressive cholestasis, and potentially liver cirrhosis. Patients develop a well …